vTv Therapeutics Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -66.5% | +22.2% | -54.1% | +4,172.9% | -77.8% | +132.1% | -37.6% | -49.6% | -99.6% | +11,200.0% | -100.0% | |
| – | +58.0% | +54.6% | -13.4% | -41.9% | -34.4% | -27.1% | -99.2% | +3.4% | -2.2% | -1.1% | -82.0% | |
| – | – | -8,792.5% | – | – | – | – | – | -49.6% | -104.5% | – | -101.6% | |
| – | +58.0% | +54.6% | -13.4% | -41.9% | -34.4% | -27.1% | +21.0% | -7.3% | +10.0% | -15.1% | +54.7% | |
| – | -22.5% | +9.1% | +14.4% | -18.6% | -7.4% | -15.1% | +70.2% | -1.2% | -2.4% | +14.6% | +9.5% | |
| – | +27.0% | +44.0% | -8.4% | -36.7% | -26.7% | -69.3% | +254.0% | -4.3% | +3.8% | -1.2% | +30.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -71.1% | -77.1% | +676.9% | +6.4% | -44.5% | -62.1% | -98.3% | +25.0% | -13.3% | -100.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -389.0% | – | – | -75.0% | -50.0% | -4,075.0% | – | +73.9% | -2,958.0% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.